A meta-analysis of the effects of ipratropium bromide in adults with acute asthma

American Journal of Medicine

Volumn 107, Issue 4, 1999, Pages 363-370

  Rodrigo, Gustavo ^a   Rodrigo, Carlos ^b   Burschtin, Omar ^c  

^a HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS   (Uruguay)

^b Centro de Terapia Intensiva   (Uruguay)

^c Department of Anesthesiology and Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; IPRATROPIUM BROMIDE;

ADULT; ASTHMA; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; META ANALYSIS; METHODOLOGY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; REVIEW;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; DRUG SYNERGISM; FENOTEROL; FORCED EXPIRATORY VOLUME; HUMANS; IPRATROPIUM; MIDDLE AGED; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0032832108     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00243-0     Document Type: Review

References (59)

1. Guidelines for the Diagnosis and Management of Asthma. 1997;US Department of Health and Human Services, NIH Publication No. 97-4051, Bethesda, Md.
2. Lipworth B.J. Treatment of acute asthma. Lancet. 350:(suppl II):1997;18-23.
3. Gross N.J. Iratropium bromide. NEJM. 319:1988;486-494.
4. Bryant D.H. Nebulized ipratropium bromide in the treatment of acute asthma. Chest. 88:1985;24-29.
5. Rebuck A.S., Chapman K.R., Abboud R., et al. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic ob-structive airway disease in the emergency room. Am J Med. 82:1987;59-64.
6. Rosler J., Reynaert M.S. A comparison of fenoterol and fenoterol and ipratropium nebulization treatment in acute asthma. Acta Ther. 13:1987;571-576.
7. Leahy B.C., Gomm S.A., Allen S.C. Comparison of nebulized salbutamol with nebulized ipratropium bromide in acute asthma. Br J Dis Chest. 77:1988;159-163.
8. O'Driscoll B.R., Taylor R.J., Horsley M.G., et al. Nebulized salbutamol with and without ipratropium bromide in the acute airflow obstruction. Lancet. i:1989;1418-1420.
9. Louw S.J., Goldin J.G., Isaacs S. Relative efficacy of nebulised ipratropium bromide and fenoterol in acute severe asthma. S Afr Med J. 77:1990;24-26.
10. Teale C., Morrison J.F., Muers M.F., et al. Response to nebulized ipratropium bromide and terbutaline in acute severe asthma. Respir Med. 86:1992;215-218.
11. Garrett J.E., Town G.I., Rodwell P., et al. Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma. J Allergy Clin Immunol. 100:1997;165-170.
12. Lin R.Y., Pesola G.R., Bakalchuk L., et al. Superiority of iratropium plus albuterol over albuterol alone in the emergency department management of adult asthma a randomized clinical trial . Ann Emerg Med. 31:1998;208-213.
13. Higgins R.M., Stradling J.R., Lane D.J. Should ipratropium bromide be added to beta-agonists in the treatment of acute severe asthma? Chest. 94:1988;718-722.
14. Summers Q.A., Tarala R.A. Nebulized ipratropium in the treatment of acute asthma. Chest. 97:1990;430-434.
15. Karpel J.P., Schacter E.N., Fanta C.H., et al. A comparison of ipratropium and albuterol versus albuterol alone for the treatment of acute asthma. Chest. 110:1996;611-616.
16. FitzGerald J.M., Grunfeld A., Pare P.D., et al. The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators versus nebulized adrenergic bronchodilator alone in acute asthma. Chest. 111:1997;311-315.
17. McFadden E.R., ElSanadi N., Strauss L., et al. The influence of parasympatholytics on the resolution of acute attacks of asthma. Am J Med. 102:1997;7-13.
18. Weber E.J., Andrew Levitt M., Covington J.K., Gambrioli E. Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm. A randomized, controlled trial. Chest. 115:1999;937-944.
19. Hedges L.V., Olkin I. Statistical Methods for Meta-Analysis. 1985;Academic Press, San Diego, Calif.
20. Hunter J.E., Schmidt F.L. Methods of Meta-Analysis. Correcting Error and Bias in Research Findings. 1990;Sage, Newbury Park, Calif.
21. British guidelines on asthma management 1995. Review and position statement . Thorax. 52:1997;S1-S24.
22. Hall J.B., Wood L.D.H. Management of the critically ill patient. Med Clin N Am. 74:1990;779-796.
23. Leatherman J. Life-threatening asthma. Clin Chest Med. 15:1994;453-479.
24. Corbridge T.C., Hall J.B. The assessment and management of adults with status asthmaticus. Am J Respir Crit Care Med. 151:1995;1296-1316.
25. McFadden E.R., Hejal R. Asthma. Lancet. 345:1995;1215-1219.
26. Beveridge R.C., Grunfeld A.F., Hodder R.V., Verbeek P.R. Guidelines for the emergency management of asthma in adults. Can Med Assoc J. 155:1996;25-37.
27. Beakes D.E. The use of anticholinergics in asthma. J Asthma. 34:1997;357-368.
28. Medical Editors' Trial Amnesty. The Cochrane Controlled Trials Register. In: The Cochrane Library. Oxford: Update Software; 1998.
29. Greennalgh T. Assessing the methodological quality of published papers. BMJ. 315:1997;305-308.
30. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 136:1987;225-244.
31. Brennan P., Silman A. Statistical methods for assessing observer variability in clinical measurements. BMJ. 304:1992;1491-1494.
32. Glass C.V. Meta-analysis in Social Research. 1981;Sage, Beverly Hills, Calif.
33. Fleiss J.L. The statistical basis of meta-analysis. Stat Meth Med Res. 2:1993;121-145.
34. Cohen J. Statistics Analysis for the Behavioral Sciences. 1977;Academic Press Inc, Orlando, Fla.
35. Ziment I., Au J.P. Anticholinergic agents. Clin Chest Med. 7:1986;454-458.
36. Strauss L., Hejal R., Galan G., et al. Observations on the effects of aerosolized albuterol in acute asthma. Am J Respir Crit Care Med. 155:1997;454-458.
37. Rodrigo C., Rodrigo G. Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma. Chest. 113:1998;593-598.
38. Cappelleri J.C., Ioannidis J.P.A., Schmid C.H., et al. Large trials versus meta-analysis of smaller trials. How do their results compare? JAMA. 276:1996;1332-1338.
39. Egger M., Davey Smith G., Schneider M., Minder C.E. Bias in meta-analysis detected by a simple graphical test. BMJ. 315:1997;629-634.
40. Cooper H.M. Statistically combining independent studies a meta-analysis of sex differences in conformity research . J Personal Soc Psychol. 37:1979;131-146.
41. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. JNCl. 22:1959;719-748.
42. Breslow N.E., Day N.E. Analysis of case-control studies. Statistical Methods in Cancer Research. Vol 1:1980;141-143 IARC Scientific, Lyon.
43. Altman D.G. Confidence intervals for the number to treat. BMJ. 317:1998;1309-1312.
44. Lanes S.F., Garrett J.E., Wentworth ChE, et al. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma. A pooled analysis of three trials. Chest. 114:1998;365-372.
45. Brophy C., Ahmed B., Bayston S., et al. How long should atrovent be given in acute asthma? Thorax. 53:1998;363-367.
46. Ward M.J., Fentem P.H., Roderick-Smith W.H., Davies D. Ipratropium bromide in acute asthma. BMJ (Clin Res Ed). 282:1981;598-600.
47. Ward M.J., McFarlane J.T., Davies D. A place for ipratropium bromide in the treatment of severe acute asthma. Br J Dis Chest. 79:1985;374-378.
48. Whyte K.F., Gould G.A., Jeffrey A.A., et al. Dose of nebulized ipratropium bromide in acute severe asthma. Respir Med. 85:1991;517-520.
49. Salome C.M., Wright W., Sedgwick C.J., et al. Acute effects of fenoterol (berotec) and ipratropium bromide (atrovent) alone and in combination on bronchial hyperresponsiveness in asthmatics. Prog Clin Biol Res. 263:1988;405-419.
50. Patrick D.M., Dales R.E., Stark R.M., et al. Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy. Chest. 98:1990;295-297.
51. Bryant D.M., Rogers P. Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma. Chest. 102:1992;742-747.
52. Coleridge J., Cameron P., Epstein J., et al. Intravenous aminophylline confers no benefit in acute asthma treated with intravenous steroids and inhaled bronchodilators. Aust NZ J Med. 23:1993;348-354.
53. Osmond M.H., Klassen T.P. Efficacy of ipratropium bromide in acute childhood asthma a meta-analysis . Acad Emerg Med. 2:1995;651-656.
54. 2 agonists for treating childhood and adolescent asthma? A systematic review. BMJ. 317:1998;971-977.
55. Oxman A.D., Guyatt G.H. Guidelines for reading literature reviews. Can Med Assoc J. 138:1988;697-703.
56. Oxman A.D., Cook D.J., Guyatt G.H. User's guides to the medical literature how to use an overview . JAMA. 272:1994;1367-1371.
57. Egger M., Zellweger-Zahner T., Schneider M., et al. Language bias in randomized controlled trials published in English and German. Lancet. 350:1997;326-329.
58. Emerson J.D., Burdick E., Hoaglin D.C., et al. An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials. Control Clin Trials. 11:1990;339-352.
59. Qureshi F., Pestian J., Davis P., et al. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. NEJM. 339:1998;1030-1035.